We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+0.64%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$650M
AUM Growth
-$107M
Cap. Flow
-$73.7M
Cap. Flow %
-11.34%
Top 10 Hldgs %
28.5%
Holding
529
New
249
Increased
8
Reduced
22
Closed
155

Sector Composition

Rank Sector Weight
1 Healthcare 27.3%
2 Financials 11.86%
3 Technology 7.97%
4 Industrials 4.89%
5 Communication Services 3.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLOVW
276
DELISTED
Clover Health Investments, Corp. Warrants
CLOVW
$134K 0.02%
83,332
PTK.WS
277
DELISTED
PTK Acquisition Corp. Warrants, each whole warrant exercisable for one half (1/2) of a share of Comm
PTK.WS
$131K 0.02%
240,000
MAACW
278
DELISTED
Montes Archimedes Acquisition Corp. Warrant
MAACW
$127K 0.02%
149,999
EUCRW
279
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$125K 0.02%
+99,998
New +$162K
XOSWW
280
Xos Inc Warrants
XOSWW
$10.5K
$124K 0.02%
66,665
PRPB.WS
281
DELISTED
CC Neuberger Principal Holdings II Redeemable warrants, each whole warrant exercisable for one Class
PRPB.WS
$124K 0.02%
112,499
VYGG.WS
282
DELISTED
Vy Global Growth Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
VYGG.WS
$122K 0.02%
59,998
PIPP.WS
283
DELISTED
Pine Island Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
PIPP.WS
$121K 0.02%
+83,331
New +$218K
GOAC.WS
284
DELISTED
GO Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock
GOAC.WS
$120K 0.02%
133,332
CCX.WS
285
DELISTED
Churchill Capital Corp II Warrants, each exercisable for one share of Class A common stock at an exe
CCX.WS
$119K 0.02%
81,288
MTTRW
286
DELISTED
Matterport, Inc. Warrant
MTTRW
$118K 0.02%
+29,998
New +$154K
IMPX.WS
287
DELISTED
AEA-Bridges Impact Corp Warrants
IMPX.WS
$113K 0.02%
125,000
MEUSW
288
DELISTED
23andMe Holding Co Warrant
MEUSW
$112K 0.02%
66,666
ARBGW
289
DELISTED
Aequi Acquisition Corp warrants
ARBGW
$111K 0.02%
+116,665
New +$176K
EPHYW
290
DELISTED
Epiphany Technology Acquisition Corp. Warrant
EPHYW
$111K 0.02%
+133,332
New +$140K
ALPN
291
DELISTED
Alpine Immune Sciences Inc
ALPN
$107K 0.02%
29,652
RMGBW
292
DELISTED
RMG Acquisition Corp. II Warrant
RMGBW
$96K 0.01%
+66,664
New +$149K
BNZIW
293
DELISTED
Banzai International Warrant
BNZIW
$95K 0.01%
+124,999
New +$143K
PMGMW
294
DELISTED
Priveterra Acquisition Corp. II Warrant to purchase Class A common stock
PMGMW
$95K 0.01%
+162,498
New +$120K
YAC.WS
295
DELISTED
Yucaipa Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A
YAC.WS
$93K 0.01%
66,665
GRSVW
296
DELISTED
Gores Holdings V, Inc. Warrant
GRSVW
$93K 0.01%
59,998
FPAC
297
DELISTED
Far Peak Acquisition Corporation
FPAC
$92K 0.01%
+83,330
New +$855K
TALKW
298
DELISTED
Talkspace Inc Warrant
TALKW
$91K 0.01%
62,499
AKICW
299
DELISTED
Sports Ventures Acquisition Corp. Warrant
AKICW
$90K 0.01%
+99,997
New +$110K
CRU.WS
300
DELISTED
Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CRU.WS
$90K 0.01%
+64,999
New +$102K

Similar funds

Monashee Investment Management's Q1 2021 Portfolio in Review

As of Q1 2021, Monashee Investment Management held 529 positions worth $650M, down 14% from $757M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Monashee Investment Management withdrew a net $73.7M in Q1 2021, closing 155 positions and reducing 22 holdings. Its most notable exit was Sigilon Therapeutics, Inc. Common Stock, an estimated $27M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 30% a quarter earlier, followed by Financials and Technology.

Against the trend, Monashee Investment Management opened a new position in Beam Therapeutics worth $21.5M.

  • Monashee Investment Management's largest Q1 2021 buy was Beam Therapeutics: 268,820 shares worth $21.5M.
  • Monashee Investment Management added most to View, Inc. Class A Common Stock in Q1 2021, an estimated $11.9M increase.
  • Monashee Investment Management's biggest Q1 2021 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $53.1M.
  • Monashee Investment Management fully exited Sigilon Therapeutics, Inc. Common Stock in Q1 2021, selling an estimated $27M.
  • Monashee Investment Management's ten largest holdings make up 28% of its $650M portfolio in Q1 2021.
  • Monashee Investment Management opened 249 new positions and closed 155 in Q1 2021.
  • Monashee Investment Management's portfolio value fell 14% quarter-over-quarter to $650M.

Based on Monashee Investment Management's 13F filing for Q1 2021, filed 14 May 2021.